Oslo, 25 February 2026 – In the fourth quarter, Vow ASA (“Vow” or the “Group”) delivered all time high revenues and improved operational performance. Following the strategy revision, which was concluded in the period, the Group aims to reinforce its position in the Maritime Solutions and Aftersales segments, while a more selective approach will be adopted in the Industrial Solutions Segment. “The fourth quarter concludes a transitional year for Vow, involving thorough analysis and clear priorities to improve cost control, project execution and working capital. Following a revisit of our strategy, the Group will pursue a more selective approach in order to balance risk and opportunities in Industrial Solutions, while reinforcing our strong position in the Maritime Solutions and Aftersales segments,” says CEO Gunnar Pedersen. Growth...

Martela Corporation, Financial Statements, 25.2.2026, at 8:00 a.m. The January–December 2025 revenue and operating result increased compared to previous year. Operating result was slightly profitable in October-December 2025, but the operating result for the year remained on loss. October–December 2025Revenue was EUR 22.8 million (24.7), representing a change of -8.0% Operating result was EUR 0.1 million (-1.8) Operating profit per revenue was 0.5% (-7.1%) The result for the period was EUR -0.5 million (-2.6) Earnings per share amounted to EUR -0.12 (-0.55)January–December 2025Revenue was EUR 93.7 million (86.7), representing a change of 8.1% Operating result was EUR -1.1 million (-6.5) Operating profit per revenue was -1.1% (-7.5%) The result for the period was EUR -3.5 million (-8.7) Earnings per share amounted to EUR -0.75...

The year 2025 in the TextMagic Group was characterised by several strategic decisions aimed at improving performance and operational efficiency in future periods. During the year, structural changes were implemented, including the sale of one business line and the initiation of the liquidation of a subsidiary, as well as the optimisation of development activities and the cost base. In 2025, the TextMagic Group generated revenue of €13,549 thousand, representing a 7% decrease compared to 2024 (2024: €14,533 thousand). The decline in revenue was significantly affected by the unfavourable exchange rates of the US dollar and the British pound. If exchange rates had remained at the 2024 level, revenue in 2025 would have totalled €14,015 thousand, representing a decrease of 4%. The Group recorded an operating loss of €611 thousand (2024: operating...

Explanatory Note: The press release issued on the morning of February 24, 2026 included language regarding changes in customer order patterns and an intention to suspend quarterly guidance. This language was included in error. The Company hereby clarifies that it has not experienced recent changes in customer order patterns in any material respect. The Company also confirms that it is not suspending quarterly guidance, and intends to continue providing quarterly guidance consistent with its current practice. There are no other changes to the Company’s reported financial results. – Record Quarterly Revenue of $148.3 million – – Quarterly Operating Profit of $17.4 million – – Quarterly Net Income of $8.1 million – – Quarterly Adjusted EBITDA1 of $30.3 million – – Record Backlog and Awarded Orders of $747.6 million – – Provides First Quarter...

CALGARY, Alberta, Feb. 24, 2026 (GLOBE NEWSWIRE) —PHX Energy is pleased to announce that its Board of Directors has declared a special cash dividend of $0.20 per common share, designated as an “eligible dividend” within the meaning of subsection 89(1) of the Income Tax Act (Canada), payable on April 1, 2026 to shareholders of record at the close of business on March 16, 2026. This special dividend reflects the Corporation’s track record of rewarding shareholders as intended under its Return of Capital Strategy (“ROCS”) while continuing to invest in operational growth. The Corporation believes it has effectively utilized both its quarterly dividend program and NCIB over the past 5 years to create shareholder rewards. With 2025 being the fourth consecutive year of record revenue while maintaining balance sheet strength and given...

DALLAS, Feb. 24, 2026 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the year ended December 31, 2025 of $57,352,000 or $1.16 per common unit. A comparison of the Partnership’s consolidated results for the twelve month periods ended December 31, 2025 and 2024 are set forth below:  Twelve Months Ended  December 31,  2025   2024Operating Revenues $ 152,832,000   $ 161,523,000Net Income $ 57,352,000   $ 92,449,000Net Income Per Common Unit $ 1.16   $ 2.13The Partnership’s independent engineering consultant estimated its total proved oil and natural gas reserves to be 15.6 million barrels of oil equivalent (mmboe) as of December 31, 2025. Approximately 86% of these reserves are attributable to the Partnership’s Royalty Properties and...

MEXICO CITY, Feb. 24, 2026 (GLOBE NEWSWIRE) — Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central and South America, today reports its unaudited financial results for the fourth quarter and full year 20251. Enrique Beltranena, President & Chief Executive Officer, said: “In 2025, Volaris once again demonstrated the resilience of our ultra-low-cost model and the strength of our market positioning. We responded swiftly to evolving geopolitical and industry dynamics, moderating capacity to protect profitability, controlling unit costs, and preserving affordability for our customers. By year-end, improving travel sentiment and the continued evolution of our low-cost, low-complexity product offering...

NEWBURYPORT, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported 2025 net income of $68.3 million, 15.8% higher than net income of $59.0 million for 2024. Adjusted net income grew 12.7% to $76.1 million. Net sales for the year ended December 31, 2025 were $602.8 million, 19.5% higher than 2024 sales of $504.4 million. GAAP and adjusted earnings per diluted common share outstanding (“EPS”) for the year ended December 31, 2025 were $8.75 and $9.76, respectively. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted gross margin, adjusted operating income, adjusted SG&A, adjusted net income and EPS, and EBITDA...

Reported positive update from Phase 2 CRDF-004 trial in first-line RAS-mutated mCRC, with the 30 mg onvansertib + FOLFIRI/bev arm demonstrating:• Robust ORR of 72.2% (vs 43.2% with combined SoC of FOLFOX/bev and FOLFIRI/bev)• Significant improvement in PFS over combined SoC (HR: 0.37, p

Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026 Improved balance sheet through multiple direct offerings; completed payments of outstanding debt HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced full year 2025 financial results and provided a corporate update. Recent Highlights Secured both public and private Human Research Ethics Committee (HREC) approvals in Australia for a Phase 1/2 clinical trial evaluating CYWC628 for the treatment of refractory diabetic foot ulcers...